Steroid-induced elevation of glucose in Alzheimer’s disease: relationship to gender, apolipoprotein E genotype and cognition

« Previous Next »Psychoneuroendocrinology
Volume 28, Issue 1 , Pages 113-120, January 2003

P.S Aisen
- Department of Neurology, Georgetown University Medical Center, 1Bles Building, 3800 Reservoir Road NW, 20007 Washington, DC, USA
- Corresponding author. Tel.: +1-202-687-7337; fax: +1-202-784-4334
J.D Berg
- Alzheimer s Disease Cooperative Study, University of California San Diego, San Diego, CA, USA
S Craft
- Geriatric Research, Education and Clinical Center, Veteran Affairs Puget Sound Health Care System, University of Washington School of Medicine, Seattle, WA, USA
- Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA
E.R Peskind
- Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA
- Mental Illness Research, Education and Clinical Center, Veteran Affairs Puget Sound Health Care System, University of Washington School of Medicine, Seattle, WA, USA
M Sano
- Gertrude H. Sergievsky Center, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
L Teri
- Department of Psychosocial and Community Health, University of Washington School of Medicine, Seattle, WA, USA
R.A Mulnard
- Institute for Brain Aging and Dementia, University of California Irvine, Irvine, CA, USA
R.G Thomas
- Departments of Family and Preventive Medicine, University of California San Diego, San Diego, CA, USA
L.J Thal
- Department of Neurosciences, University of California at San Diego, San Diego, CA, USA